(Q47659445)

4 February 2018

title

Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes (English)

1 reference

4 February 2018

main subject

Vibrio vulnificus

object named as

Vibrio vulnificus

1 reference

1

1 reference

4 February 2018

Belén Fouz

series ordinal

2

1 reference

4 February 2018

Carmen Amaro

series ordinal

3

1 reference

4 February 2018

publication date

1 February 2004

1 reference

4 February 2018

Fish and Shellfish Immunology

published in

1 reference

4 February 2018

volume

16

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

93-105

1 reference

4 February 2018

Indole-positive Vibrio vulnificus isolated from disease outbreaks on a Danish eel farm.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Transmission to eels, portals of entry, and putative reservoirs of Vibrio vulnificus serovar E (biotype 2).

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Isolation of a new serovar of Vibrio vulnificus pathogenic for eels cultured in freshwater farms

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Field testing of a vaccine against eel diseases caused by Vibrio vulnificus

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Route of vaccine administration: effects on the specific humoral response in rainbow trout Oncorhynchus mykiss

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Uptake and processing of biofilm and free-cell vaccines of Aeromonas hydrophila in indian major carps and common carp following oral vaccination--antigen localization by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Electrophoretic analysis of heterogeneous lipopolysaccharides from various strains ofVibrio vulnificus biotypes 1 and 2 by silver staining and immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

The chemotactic response of Vibrio anguillarum to fish intestinal mucus is mediated by a combination of multiple mucus components

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

The kinetics of antibody production in mucus and serum of European eel (Anguilla anguilla L.) after vaccination against Vibrio vulnificus: development of a new method for antibody quantification in skin mucus

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Affinity purification of antigen-specific serum immunoglobulin from the European eel (Anguilla anguilla)

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

The lipopolysaccharide O side chain of Vibrio vulnificus serogroup E is a virulence determinant for eels

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Efficacy of different administration routes for vaccination against Vibrio anguillarum in Atlantic halibut (Hippoglossus hippoglossus L.).

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Mucosal immune response of spotted sand bass Paralabrax maculatofasciatus (Steindachner, 1868) orally immunised with an extracellular lectin of Aeromonas veronii

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

Immunization of carp (Cyprinus carpio) with a Vibrio anguillarum bacterin: indications for a common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1050-4648%2803%2900036-6

7 January 2021

10.1016/S1050-4648(03)00036-6

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15123314

1 reference

4 February 2018